Unlike in many other types of cancers such as melanoma, cervical, renal, hepatocellular and breast cancer where Tregs are pro-tumoral and associated with poor patient prognosis, recent studies in both mice and human indicate that Tregs are protective against APC-mutation-mediated intestinal tumorigenesis (48, 49). This evidence concerns the gene APC and breast cancer.